Principles of Drug Action
Download
Report
Transcript Principles of Drug Action
Pharmacology: Studying the
principles of Drug Action
Pharmacokinetics
Pharmacodynamics: Drug action
Two ways to measure drug effects:
Psychopharmacology and
Neuropharmacology
Pharmacokinetics
I. Administration
II. Absorption & distribution
III. Binding and bioavailability
IV. Inactivation/Biotransformation (metabolization)
V. Elimination/excretion
I. Administration
A. Dose or dosage
Calculation: Take the desired or
prescribed dose (typically in mg/kg) and
multiply by the person’s mass (in kg).
Thus, for example,
0.10mg/kg x 60kg = 6 mg dose
Dosage may also be measured in mg/dl
of blood plasma, but that is after
administration and absorption.
B. Administration methods
1. Oral
Advantages and disadvantages
Formulations:
• Elixirs and syrups
• Tablets, capsules, and pills
Historic formulations:
• Powder (“Take a powder”)
• Cachets
• Lozenges and pastilles
B. More administration
methods
2. Parenteral (Injection)
a. Intravenous
b. Intramuscular
c. Subcutaneous
d. Intracranial
e. Epidural
f. Intraperitoneal
B. Administration methods,
continued
3. Respiratory
4. Transcutaneous or transdermal
5. Orifice membranes
a. Inhalation v. intranasal (snorting)
b. Smoke (Solids in air suspension)
c. Volatile gases
a. Sublingual
b. Rectal: Suppositories or enemas
c. Vaginal: pessaries or douches (1860)
d. Other orifices: bougies
6. Topical
Pharmacokinetics
I. Administration
II. Absorption & distribution
Bioavailability
III. Binding
IV. Inactivation/biotransformation (metabolization)
V. Elimination/excretion
II. A. Absorption
1. Absorption Principles
2. Absorption Barriers
3. Absorption mechanics
1. Absorption Principles
a. General principle: Diffusion, which depends on
i. Solubility (fat and/or water)
ii. Molecular diameter
iii. Volatility (air)
iv. Affinity (Proteins, water [hydrophilic], oil
b. Absorption is influenced by amount of blood
flow at the site of administration
2. Absorption Barriers
Barriers to absorption include
Mucous layers
Membrane pores
Cell walls
First-pass metabolism
Placenta
Blood proteins
Fat isolation
Blood-brain barrier
• Exceptions: Area postrema, median eminence of
hypothalamus
The blood-brain barrier
Glial feet
Basement
membrane
(Pia mater)
Absorption Barriers
To review, barriers to absorption include
Mucous layers
Membrane pores
Cell walls
First pass metabolism
Placenta
Blood proteins
Fat isolation
Blood-brain barrier
3. Absorption Mechanics
For each drug, water and fat
solubility vary.
Relative solubilities depend on
i. pH of the drug
ii. pH of the solution
iii. pKa of the drug
Solubility percentages depend on
ionization ratios
Determining the pKa of a
drug
Solution pH: 0
Solution pH:
1
8
2
9
3
10
4
11
5
6
7
12
13
14
Determining the pKa of a
drug
% Ionized
2
8
16
26
38
50
62
74
Solution pH: 0
1
2
3
4
5
6
7
% Ionized
84
92
98
99
99
99
99
Solution pH:
8
9
10
11
12
13
14
% Ionization for Darnital
120
% Ionization
100
80
60
40
20
0
0
1
2
3
4
5
6
7
8
pH of solution
9
10 11 12 13 14
Relative solubilities
Solution pH:
Drug pH:
< 7 (Acid)
> 7 (Base)
< 7 (Acid)
Un-ionized,
Fat soluble
Ionized,
Water soluble
> 7 (Base)
Ionized,
Un-ionized,
Water soluble Fat soluble
Computing Ionization Ratios
According to the Henderson-Hasselbalch
equation, the difference between the pH
of the solution and the pKa of the drug is
the common logarithm of the ratio of
ionized to unionized forms of the drug.
For acid drugs
log(ionized/unionized) = pH - pKa, or
ratio of ionized to unionized is 10X / 1, where
X = pH – pKa
Computing ionization ratios,
2
For basic drugs, everything is the
same except that the ratio reverses:
Log(unionized/ionized) = pH – pKa, or
Ratio of unionized to ionized is 10X / 1,
where
X = pH – pKa
Examples
Darnital, a weak acid, has a pKa of 5.5.
Taken orally, it is in a stomach solution of
pH 3.5.
pH – pKa = 3.5 – 5.5 = -2
Since Darnital is an acid drug, we use the
alphabetical formula ionized/unionized.
ionized/unionized = 10-2/1= 1/100
For every 1 molecule of Darnital that is
ionized, 100 are unionized. Darnital in
the stomach is highly fat soluble.
But look what happens…
The highly fat soluble Darnital readily
crosses the stomach membranes and
enters blood plasma, which has a pH of
7.5
pH – pKa = 7.5 – 5.5 = 2
ionized/unionized = 102/1= 100/1
For every 100 molecules of Darnital that
are ionized, only 1 is unionized. Darnital
in the blood is not very fat soluble.
Darnital will be subject to ion trapping.
Another example
Endital, a weak base with a pKa of 7.5
is dissolved in the stomach, pH 3.5
pH – pKa = 3.5 – 7.5 = -4
Since Endital is a base drug, we use
the ratio backwards:
unionized/ionized.
unionized/ionized = 10-4/1= 1/10,000
In the stomach, Endital will be mostly
ionized, and not very fat soluble.
But…
If we inject Endital intravenously into
the blood, with a pH of 7.5,
pH – pKa = 7.5 – 7.5 = 0
unionized/ionized = 100 = 1/1
In the blood, Endital will be equally
ionized and unionized. Half of the
molecules of Endital will be fat
soluble, and will readily leave the
blood and enter the brain.
A dynamic equilibrium follows.
An oddity
Caffeine is a base drug, but it has a pKa of 0.5
pH – pKa = 3.5 – 0.5 = 3
Since caffeine is a base drug, we use the ratio
backwards: unionized/ionized.
unionized/ionized = 103/1= 1000/1
In the stomach, caffeine will be mostly
unionized, and fat soluble!
In the blood, caffeine will be even more
unionized and fat soluble:
pH – pKa = 7.5 – 0.5 = 7, ratio = 107/1=
10,000,000/1. Caffeine is a 600 pound gorilla.
2b. Distribution
The generalized distribution of a drug
throughout the body controls the
movement of a drug by its effect on
ionization ratios
Distribution also controls how long a drug
acts and how intense are its effects
Generalized distribution of a drug
accounts for most of the side effects
produced
Is there a magic bullet?
Mechanisms of distribution
Blood circulation: The crucial minute
But blood flow is greater to crucial organs
than to muscle, skin, or bone.
Blood circulation is the main factor affecting
bioavailability.
Lymphatic circulation
Depot binding
CSF circulation: The ventricular system
Distribution half-life and
therapeutic levels
Distribution half-life: the amount of time
it takes for half of the drug to be
distributed throughout the body
Therapeutic level: the minimum amount
of the distributed drug necessary for
the main effect.
Half-life curves
Blood level
Resultant
Elimination
Distribution
2
4
6 8 10 12
Time in hours
14
Pharmacokinetics
1. Administration
2. Absorption and distribution
3. Binding and bioavailability
4. Inactivation/biotransformation
5. Elimination/excretion
Pharmacokinetics
1. Administration
2. Absorption
3. Distribution and bioavailability
4. Biotransformation and
elimination
4. Elimination
Routes of elimination: All body
secretions
Air
Perspiration, saliva, milk
Bile
Urine
Regurgitation
Kidney action
Liver enzyme activity: Generalized
Enzyme activity
Enzymes in gi tract cells
Buspirone and grapefruit juice
Enzymes in hepatocytes
Cytochrome P-450 families: CYP1-3
• Cross-tolerance
Biotransformation
• Type I and type II
• Metabolites are larger, less fat soluble, more water
soluble
• Metabolite activity is usually lowered
Elimination phenomena
Elimination half-life and side effects
Tolerance and Mithradatism
Metabolic tolerance or enzymeinduction tolerance
Cross-tolerance: Carbamazepine and
fluoxetine (Tegretol and Prozac)
Cellular-adaptive tolerance
Behavioral conditioning and statedependent tolerance
Tolerance
More tolerance phenomena
Tachyphylaxis
Acute tolerance: The BAC curve
Mixed tolerance
Reverse tolerance or sensitization and
potentiation: Fluvoxamine and
clozapine; Zantac or Tagamet and
alcohol
Balancing distribution and
elimination
Elimination half-life and hangovers
Accumulation dosing: The 6 half-life
rule and regular dosing
Steady-state dosing
Therapeutic drug monitoring (TDM)
Accumulation dosing
A 1 B
2 C
3 D 4 E
5 F
Letters = doses; numbers = half-lives
6 G 7
Dependence and Addiction
Physiological dependence: The
abstinence syndrome
Cross-dependence
Habituation and conditioning
Addiction and behavioral
reinforcement
Positive reinforcement
Negative reinforcement
Automatic enemas
Nineteenth century inhaler